Medical Device Regulation in Czech Republic
The Czech Republic (Czechia) regulates medical devices under the EU Medical Device Regulation (EU MDR 2017/745). The State Institute for Drug Control (SÚKL) is the national competent authority responsible for market surveillance, vigilance, and oversight of medical devices. The Czech Republic has a growing medical device manufacturing sector and is fully integrated into the EU regulatory system.
Recent Regulatory Updates
Showing the latest 3 updates. Sign up to see more
New EU supply disruption reporting, MDCG guidance.
New reimbursement codes for multi-injection HA devices
MD/IVD advertising, EUDAMED, and new MDCG guidance.
Sources Tracked by Qalico
Qalico continuously monitors 10 references across guidelines, regulations, and standards for Czech Republic.
Guidelines
Device Classification
The Czech Republic follows the EU MDR classification system based on intended purpose and inherent risk. Class I covers low-risk devices such as examination gloves and walking aids. Class IIa covers low-moderate risk devices such as blood pressure monitors and suction equipment. Class IIb covers moderate-high risk devices such as anaesthesia machines and surgical lasers. Class III covers the highest-risk devices such as implantable pacemakers and total hip replacements.
Official classification guidance →Official Guidance Documents
Official SÚKL guidance on medical device regulation in the Czech Republic, including registration requirements and vigilance reporting.
The complete text of EU Regulation 2017/745, directly applicable in the Czech Republic.
European Database on Medical Devices for registration, UDI, and certificate management across the EU.
Standards & Key Principles
Applicable Standards
Key Principles
- Medical devices must bear the CE mark under EU MDR 2017/745 to be placed on the Czech market.
- Manufacturers must register with EUDAMED and comply with UDI requirements.
- Higher-risk devices require conformity assessment by an EU-notified body.
- Non-EU manufacturers must appoint an authorized representative within the EU.
- Post-market surveillance and vigilance reporting to SÚKL are mandatory obligations.
Pre-Market Requirements
Devices must conform to EU MDR 2017/745 and bear the CE mark. A notified body must be involved for Class IIa, IIb, and III devices.
Complete technical documentation per EU MDR Annexes II and III is required, including design information, risk analysis, and clinical evidence.
Clinical evaluations are mandatory for all device classes. Clinical investigations may be required and must be authorized by SÚKL.
Manufacturers and devices must be registered in EUDAMED, including UDI-DI assignment and actor registration.
Post-Market Requirements
A PMS system is mandatory. Periodic safety update reports are required for Class IIa, IIb, and III devices.
Serious incidents and field safety corrective actions must be reported to SÚKL in accordance with EU MDR Article 87 and national implementing legislation.
PMCF is required to proactively collect clinical data to confirm ongoing safety and performance throughout the device lifecycle.
International Recognition & Reliance
As an EU member state, CE-marked devices are recognized across all EU/EEA markets.
CE-marked devices from EU member states are recognized in Switzerland under the MRA framework.